News

Under the deal, the companies will initially work on chemical compounds that target TDP-43, a protein that is a prime suspect in the disease. With their three year

The company is developing NBI-98854 to address the unmet medical needs of patients suffering from tardive dyskinesia (TD). The trial aims to evaluate once-daily NBI-98854 (12.5mg and 50mg)

Fluzone Intradermal, which uses microinjection system for intradermal delivery, is indicated for active immunization of adults 18 through 64 years of age against influenza. The injection features an

The cloud-based version of the SMRT Analysis software suite is designed to offer computing that scales to meet the data analysis needs for SMRT sequencing and supports a

The trial aims to evaluate the safety and tolerability of TrasGEX, a glycooptimized HER2 biobetter antibody. TrasGEX is developed using GlycoExpress, the company’s development and production platform based

Prior to joining PPD, Hill worked with IMS Health as the president of IMS Consulting Group. Before IMS, Hill served as the senior vice president for Acumen Sciences.

Curaxins are synthetic small molecules intended to simultaneously target major cell stress response pathways that are frequently deregulated in cancer. Incuron CEO Andrei Leonov said this prestigious Skolkovo

The combined company is expected to have a diversified revenue base from 12 products currently marketed in the US in the CNS and women’s health areas. Following the

The approval has been granted for 100mg/ml and 150mg/ml strengths. Enoxaparin Sodium Injection is the generic version of Lovenox of Sanofi-aventis and is indicated for the treatment of